Charles River Laboratories (CRL) Annual Income Statement (USD)
CRL Quarterly Financials (USD)
Frequently Asked Questions About Charles River Laboratories (CRL) Stock
Charles River Laboratories's (CRL) last reported annual revenue was USD 4.13 Billion.
Charles River Laboratories's (CRL) annual revenue growth rate based on the revenue reported in the past 5 years is : 12.75%
Charles River Laboratories's(CRL) is profitable as of its last reported annual financials.
The net profit margin for Charles River Laboratories's(CRL) from its laster reported year is 11.49%
The return on equity (ROE) for Charles River Laboratories's(CRL) from its last reported annual financials is : 12.60%
The return on assets (ROA) for Charles River Laboratories's(CRL) from its last reported annual financials is : 4.99%
The return on invested capital (ROIC) for Charles River Laboratories's(CRL) from its last reported annual financials is : 8.66%
The Debt to Equity ratio for Charles River Laboratories's(CRL) from its last reported annual financials is : 73.60%
The dividend yield for Charles River Laboratories's(CRL) from its laster reported year is 0.00%
Charles River Laboratories's(CRL) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CRL !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
